Pensionfund Sabic Sells 3,600 Shares of Cardinal Health, Inc. $CAH

Key Points

• Pensionfund Sabic has reduced its stake in Cardinal Health by 25.4%, bringing its holdings down to 10,600 shares valued at approximately $1.46 million.
• Multiple institutional investors have increased their positions in Cardinal Health, with Wellington Management Group expanding its stake by 1,666.7% to over 2.38 million shares valued at around $328.47 million.
• Cardinal Health reported earnings per share (EPS) of $2.08 for the last quarter, exceeding estimates, while the company has set its FY 2026 EPS guidance between 9.300 and 9.500.

Pensionfund Sabic trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 25.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,600 shares of the company's stock after selling 3,600 shares during the period. Pensionfund Sabic's holdings in Cardinal Health were worth $1,460,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Focus Partners Wealth grew its position in shares of Cardinal Health by 20.3% during the 4th quarter. Focus Partners Wealth now owns 18,197 shares of the company's stock valued at $2,152,000 after acquiring an additional 3,076 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Cardinal Health by 86.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,467 shares of the company's stock valued at $7,625,000 after buying an additional 29,919 shares in the last quarter. OMERS ADMINISTRATION Corp raised its stake in Cardinal Health by 20.1% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 10,310 shares of the company's stock valued at $1,219,000 after purchasing an additional 1,729 shares during the period. Nomura Holdings Inc. increased its stake in Cardinal Health by 138.7% in the 4th quarter. Nomura Holdings Inc. now owns 9,783 shares of the company's stock worth $1,157,000 after acquiring an additional 5,684 shares during the last quarter. Finally, Mufg Securities Americas Inc. bought a new stake in Cardinal Health in the 4th quarter worth approximately $423,000. 87.17% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on CAH shares. Bank of America lifted their price objective on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research note on Tuesday, June 10th. Leerink Partners reduced their price objective on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 12th. Argus set a $189.00 target price on Cardinal Health in a report on Friday, August 22nd. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Wells Fargo & Company reiterated an "overweight" rating and issued a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $165.93.

Cardinal Health Stock Down 1.2%

CAH traded down $1.83 during trading hours on Tuesday, reaching $148.44. 2,852,685 shares of the company's stock traded hands, compared to its average volume of 2,064,407. The firm has a 50-day moving average price of $154.16 and a 200 day moving average price of $148.08. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44. The firm has a market capitalization of $35.45 billion, a PE ratio of 18.24, a PEG ratio of 1.27 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter in the previous year, the business earned $1.84 EPS. Cardinal Health's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is presently 31.63%.

Insider Buying and Selling at Cardinal Health

In related news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares of the company's stock, valued at $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.09% of the stock is currently owned by company insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.